Limitations of Anti-Angiogenic Treatment of Tumors
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference81 articles.
1. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004
2. Inhibition of angiogenesis in the treatment of non-small cell lung cancer;Keedy;Cancer Sci,2007
3. Gastrointestinal perforation due to bevacizumab in colorectal cancer;Saif;Ann Surg Oncol,2007
4. Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects;Hartmann;Curr Drug Metab,2009
5. A preclinical and clinical review of aflibercept for the management of cancer;Gaya;Cancer Treat Rev,2012
Cited by 98 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Natural products‐based antiangiogenic agents: New frontiers in cancer therapy;Food Frontiers;2024-09
2. Targeting the tumour vasculature: from vessel destruction to promotion;Nature Reviews Cancer;2024-08-29
3. COE targets EphA2 to inhibit vasculogenic mimicry formation induced by hypoxia in hepatocellular carcinoma;Frontiers in Pharmacology;2024-07-10
4. Nanomedicine-based targeting delivery systems for peritoneal cavity localized therapy: A promising treatment of ovarian cancer and its peritoneal metastasis;Chinese Chemical Letters;2024-07
5. An Overview of Cancer Biology, Pathophysiological Development and It’s Treatment Modalities: Current Challenges of Cancer anti-Angiogenic Therapy;Cancer Investigation;2024-06-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3